메뉴 건너뛰기




Volumn 3, Issue 2, 2016, Pages e63-

Discontinuation therapy: The role of emotion and cognition

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC MYELOID LEUKEMIA; COGNITION; EMOTION; HIGH RISK BEHAVIOR; HUMAN; LETTER; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT WITHDRAWAL;

EID: 84957921641     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(16)00005-3     Document Type: Letter
Times cited : (1)

References (5)
  • 1
    • 84960941451 scopus 로고    scopus 로고
    • Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
    • Imagawa J, Tanaka H, Okada M, et al. Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. Lancet Haematol 2015, 2:e528-e535.
    • (2015) Lancet Haematol , vol.2 , pp. e528-e535
    • Imagawa, J.1    Tanaka, H.2    Okada, M.3
  • 2
    • 78049528573 scopus 로고    scopus 로고
    • Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
    • Mahon FX, Rea D, Guilhot J, et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010, 11:1029-1035.
    • (2010) Lancet Oncol , vol.11 , pp. 1029-1035
    • Mahon, F.X.1    Rea, D.2    Guilhot, J.3
  • 3
    • 84898807988 scopus 로고    scopus 로고
    • Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia
    • Sanford D, Kyle R, Lazo Langner A, et al. Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia. Curr Oncol 2014, 21:e241.
    • (2014) Curr Oncol , vol.21
    • Sanford, D.1    Kyle, R.2    Lazo Langner, A.3
  • 4
    • 84969262681 scopus 로고    scopus 로고
    • Rationale and protocol of CML study: cognitive and emotional impact of discontinuation of therapy in patients with chronic myeloid leukemia
    • published online Dec 8.
    • Riva S, Mazzocco K, Pravettoni G Rationale and protocol of CML study: cognitive and emotional impact of discontinuation of therapy in patients with chronic myeloid leukemia. Tumori 2015, published online Dec 8. 10.5301/tj.5000451.
    • (2015) Tumori
    • Riva, S.1    Mazzocco, K.2    Pravettoni, G.3
  • 5
    • 84959472030 scopus 로고    scopus 로고
    • The choice dilemma in chronic hematological conditions: why choosing is not only a medical issue? A psycho-cognitive perspective
    • published online Dec 27.
    • Renzi C, Riva S, Masiero M, Pravettoni G The choice dilemma in chronic hematological conditions: why choosing is not only a medical issue? A psycho-cognitive perspective. Crit Rev Oncol Hematol 2015, published online Dec 27. http://dx.doi.org/10.1016/j.critrevonc.2015.12.010.
    • (2015) Crit Rev Oncol Hematol
    • Renzi, C.1    Riva, S.2    Masiero, M.3    Pravettoni, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.